Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2021 Earnings

8NovConfirmed

Q1 2021

Q2 2021

Q3 2021

Q4 2021

-0.51

-0.37

-0.23

-0.09

Details

Expected EPS

-0.26

Actual EPS

-0.09

Surprise EPS

0.17

Surprise Percent

+65.38%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.09 per share for Q4 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.